There are more than 200 different forms of primary immune deficiency diseases (PIDDs) and, though they affect only about 500,000 people in the United States, these diseases may be chronic and debilitating. Since the 1980s NIAID-supported investigators have been examining the causes and complications of PIDDs to improve the lives of patients and families.
NIAID aims to improve diagnosis, facilitate genetic counseling, and explore new treatments and preventions for PIDDs. It is home to a Primary Immune Deficiency Clinic, which provides diagnoses and disease management recommendations to those whose lives are touched by PIDDs.
Media Availability: NIH Researchers Describe Spontaneous Cure of Rare Immune Disease—Feb. 5, 2015
NIAID Researchers Identify TRIANGLE Disease—Dec. 18, 2014
New Variation of Genetic Immune Disorder Identified—Dec. 8, 2014
DOCK8 Helps Mobilize Immune Cells in the Skin—Nov. 24, 2014
News From NIAID-Supported Institutions
Last Updated February 27, 2015